None listed
Conditions
Brief summary
To observe on eye performance of three marketed contact lenses.
Interventions
Comparison of on eye performance of three marketed contact lenses used on a daily wear schedule. The contact lenses tested include 1 Day Acuvue Moist, 1 Day Acuvue Trueye and Acuvue Oasys. The trial will last for three months and the performance of the lenses on eye and subjective responses will be assessed.
Sponsors
Alcon Laboratories
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
Participants in this trial must: - be able to read and comprehend English and give informed consent as demonstrated by signing a record of informed consent; - be at least 18 years old; - be willing to comply with the wearing and clinical trial visit schedule as directed by the Investigator; - have ocular health findings considered to be “normal” and which would not prevent the participant from safely wearing contact lenses; - Has vision correctable to at least 6/12 (20/40) or better in each eye with contact lenses; - may be experienced or inexperienced at wearing contact lenses.
Exclusion criteria
Participants in this trial must not have: - Any pre-existing ocular irritation, injury or condition (including keratoconus and herpes keratitis) of the cornea, conjunctiva or eyelids that would preclude contact lens fitting and safe wearing of contact lenses; - Any systemic disease that adversely affects ocular health e.g. diabetes, Graves disease, and auto-immune diseases such as ankylosing spondylitis, multiple sclerosis, Sjögrens syndrome and systemic lupus erythematosis. Conditions such as systemic hypertension and arthritis do not automatically exclude prospective participants; - Use of or a need for concurrent category S3 and above ocular medication up to 12 weeks prior to and during the trial; - Use of or a need for any systemic medication or topical medications which may alter normal ocular findings/are known to affect a participant’s ocular health/physiology or contact lens performance either in an adverse or beneficial manner; N.B. Systemic antihistamines are allowed on an ‘as needed basis’, provided they are not used prophylactically during the trial; - Eye surgery within 12 weeks immediately prior to enrolment for this trial; - Previous corneal refractive surgery; - Contraindications to contact lens wear; - Currently enrolled in another clinical trial; - Participation in a clinical trial within the previous 2 weeks or participation in a ‘short term’ clinical trial within the previous 48 hours; - Be pregnant - Allergy or intolerance to topical anaesthetics
Outcome results
None listed